Novartis' drug ianalumab meets Phase III endpoints in Sjögren's disease trials, potentially offering the first targeted therapy for this chronic autoimmune disorder.
Tropical Storm Erin expected to intensify into a major hurricane, with uncertainty around its exact path beyond the five-day forecast period.
Rumble plans $1.17B acquisition of Northern Data to boost AI and cloud computing capabilities, with Tether's support and potential revenue boost.
Novartis' drug ianalumab meets Phase III endpoints in Sjögren's disease trials, potentially offering the first targeted therapy for this chronic autoimmune disorder.
Tropical Storm Erin expected to intensify into a major hurricane, with uncertainty around its exact path beyond the five-day forecast period.
Rumble plans $1.17B acquisition of Northern Data to boost AI and cloud computing capabilities, with Tether's support and potential revenue boost.